Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Atrial Fibrillation / complications
  • Atrial Fibrillation / therapy
  • Benzimidazoles / adverse effects*
  • Benzimidazoles / therapeutic use
  • Cerebral Hemorrhage / chemically induced*
  • Cerebral Hemorrhage / complications
  • Cerebrovascular Circulation
  • Dabigatran
  • Electric Countershock
  • Fatal Outcome
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Stroke / chemically induced*
  • Stroke / etiology
  • Tissue Plasminogen Activator / adverse effects*
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / therapeutic use

Substances

  • Benzimidazoles
  • Fibrinolytic Agents
  • beta-Alanine
  • Tissue Plasminogen Activator
  • Dabigatran